# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875045-18-000019
Filing Date
2018-07-24
Accepted
2018-07-24 16:53:51
Documents
120
Period of Report
2018-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | biib-2018630x10q.htm | 10-Q | 2201706
2 | EXHIBIT 31.1 | biib-2018630xex311.htm | EX-31.1 | 14188
3 | EXHIBIT 31.2 | biib-2018630xex312.htm | EX-31.2 | 14942
4 | EXHIBIT 32.1 | biib-2018630xex321.htm | EX-32.1 | 10781
11 |  | acquiredinprocessrd.jpg | GRAPHIC | 24176
12 |  | amortofacqintangibleassets.jpg | GRAPHIC | 22859
13 |  | anticd20therapeuticprograms.jpg | GRAPHIC | 49685
14 |  | biogenlogostandard.jpg | GRAPHIC | 756402
15 |  | biosimilars.jpg | GRAPHIC | 26667
16 |  | collaborationprofitshare.jpg | GRAPHIC | 23116
17 |  | costofsales.jpg | GRAPHIC | 34966
18 |  | financialhighlights.jpg | GRAPHIC | 36552
19 |  | gainlossonfvremeasurement.jpg | GRAPHIC | 23600
20 |  | incometaxprovision.jpg | GRAPHIC | 34353
21 |  | interferon.jpg | GRAPHIC | 37647
22 |  | noncontrollinginterest.jpg | GRAPHIC | 21549
23 |  | otherincomeexpense.jpg | GRAPHIC | 23451
24 |  | otherrevenue.jpg | GRAPHIC | 32317
25 |  | rdpiechart2017.jpg | GRAPHIC | 35890
26 |  | rdpiechart2018.jpg | GRAPHIC | 35763
27 |  | researchanddevelopment.jpg | GRAPHIC | 76202
28 |  | reservesfordisandallowances.jpg | GRAPHIC | 38731
29 |  | restructuring.jpg | GRAPHIC | 20794
30 |  | sellinggeneralandadmin.jpg | GRAPHIC | 24208
31 |  | spinraza.jpg | GRAPHIC | 34411
32 |  | tecfidera.jpg | GRAPHIC | 40788
33 |  | tysabri.jpg | GRAPHIC | 38314
34 |  | zinbryta.jpg | GRAPHIC | 23881
| Complete submission text file | 0000875045-18-000019.txt |  | 14139728

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE DOCUMENT | biib-20180630.xml | EX-101.INS | 3281709
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20180630.xsd | EX-101.SCH | 72690
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | biib-20180630_cal.xml | EX-101.CAL | 103144
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | biib-20180630_def.xml | EX-101.DEF | 359334
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20180630_lab.xml | EX-101.LAB | 888827
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20180630_pre.xml | EX-101.PRE | 546796

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 18966939
SIC: 2836 Biological Products, (No Diagnostic Substances)